Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCALEIA, Ana Isabel
dc.contributor.authorPIRES, Catarina
dc.contributor.authorPEREIRA, Jacinta de Fatima
dc.contributor.authorPINTO-RIBEIRO, Filipa
dc.contributor.authorLONGATTO-FILHO, Adhemar
dc.identifier.citationACTA CYTOLOGICA, v.64, n.4, p.332-343, 2020
dc.description.abstractBackground:Cervical cancer is the fourth most common cancer in the world. A raised incidence and mortality parallel a low participation rate in screening, namely screening in poor countries and among specific populations of developed countries. Cervical or vaginal self-sampling may increase adherence to screening due to its low costs and elevated sensibility and specificity. Our main goal was to compare self-sampling with physician sampling and to evaluate the participation rate of women formerly non-adherent to cervical cancer screening.Study Design:We identified relevant studies from PubMed. Studies were eligible for inclusion if they fulfilled the following criteria: women aged between 16 and 80 years, poor and developed countries that use self-sampling, women with a low participation rate in screening and studies published since 2013. After fully reading the articles, data were extracted to an Excel sheet to -display all relevant information in an organized manner. -Results:We identified 18 studies, which altogether enrolled 22,118 women. Self-sampling and physician sampling are quite similar regarding the HPV detection rate. Women have a low participation rate mainly because of limited access to health services, religious and culture beliefs, and lack of time due to several demanding tasks in daily life. Self-sampling shows a significant increase in acceptability and preference compared to physician sampling.Conclusion:Self-sampling is a reliable method to involve women in opportunistic or organized screening programs for cervical cancer prevention.eng
dc.relation.ispartofActa Cytologica
dc.subjectCervical cancer screeningeng
dc.subjectScreening adherenceeng
dc.subject.otherhuman-papillomavirus infectioneng
dc.titleSelf-Sampling as a Plausible Alternative to Screen Cervical Cancer Precursor Lesions in a Population with Low Adherence to Screening: A Systematic Revieweng
dc.rights.holderCopyright KARGEReng
dc.type.versionpublishedVersioneng, Ana Isabel:Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal, Catarina:Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal, Jacinta de Fatima:Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal, Filipa:Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
hcfmusp.relation.referenceAllende G, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6401-5eng
hcfmusp.relation.referenceBishop E, 2019, BIORESEARCH OPEN ACC, V8, P65, DOI 10.1089/biores.2018.0040eng
hcfmusp.relation.referenceBroquet C, 2015, AFR HEALTH SCI, V15, P755, DOI 10.4314/ahs.v15i3.8eng
hcfmusp.relation.referenceChatzistamatiou K, 2017, J OBSTET GYNAECOL, V37, P1059, DOI 10.1080/01443615.2017.1323197eng
hcfmusp.relation.referenceDoorbar J, 2019, PAPILLOMAVIRUS RES, V7, P176, DOI 10.1016/j.pvr.2019.04.005eng
hcfmusp.relation.referenceEl-Zein M, 2019, CANCER EPIDEM BIOMAR, V28, P1134, DOI 10.1158/1055-9965.EPI-18-1338eng
hcfmusp.relation.referenceEsber A, 2018, MALAWI MED J, V30, P61, DOI 10.4314/mmj.v30i2.2eng
hcfmusp.relation.referenceGottschlich A, 2017, J GLOB ONCOL, V3, P444, DOI 10.1200/JGO.2016.005629eng
hcfmusp.relation.referenceHaguenoer K, 2014, GYNECOL ONCOL, V134, P302, DOI 10.1016/j.ygyno.2014.05.026eng
hcfmusp.relation.referenceKhoo SP, 2018, SEX TRANSM INFECT, V94, P276, DOI 10.1136/sextrans-2017-053320eng
hcfmusp.relation.referenceLaskow B, 2017, INT J GYNECOL OBSTET, V138, P194, DOI 10.1002/ijgo.12204eng
hcfmusp.relation.referenceLorenzi AT, 2013, GYNECOL ONCOL, V131, P131, DOI 10.1016/j.ygyno.2013.07.092eng
hcfmusp.relation.referenceMaza M, 2018, PREV MED, V114, P149, DOI 10.1016/j.ypmed.2018.06.017eng
hcfmusp.relation.referenceMbatha J N, 2017, BMC Res Notes, V10, P702, DOI 10.1186/s13104-017-3045-3eng
hcfmusp.relation.referenceNghiem VT, 2016, CANCER EPIDEM BIOMAR, V25, P807, DOI 10.1158/1055-9965.EPI-15-1044eng
hcfmusp.relation.referencePoli UR, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.008078eng
hcfmusp.relation.referencePossati-Resende JC, 2020, ACTA CYTOL, V64, P7, DOI 10.1159/000493333eng
hcfmusp.relation.referenceStanczuk G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010660eng
hcfmusp.relation.referenceStumbar SE, 2019, PRIMARY CARE, V46, P117, DOI 10.1016/j.pop.2018.10.011eng
hcfmusp.relation.referenceVahabi M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3564-1eng
hcfmusp.relation.referenceWiner RL, 2016, J COMMUN HEALTH, V41, P1049, DOI 10.1007/s10900-016-0189-3eng
hcfmusp.relation.referenceYeh PT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001351eng
hcfmusp.relation.referenceZehbe I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011754eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/Outros
Outros departamentos - FM/Outros

Artigos e Materiais de Revistas Científicas - LIM/14
LIM/14 - Laboratório de Investigação em Patologia Hepática

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.